Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  324 results for ""RITUXIMAB""

Your Filters

Publication : new england journal of medicine Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman's Disease.

  • Authors : Eskandari SK; From the Department of Metabolic Diseases, Beatrix Children's Hospital (S.K.E., F.B., F.J.S., C.M.A.L.), and the Department of Surgery (S.K.E.), University Medical Center (UMC) Groningen, Groningen, the Division of Pediatrics (E.G.M.R., M.B., P.M.H., C.A.L.) and the Department of Metabolic Diseases (P.M.H.), UMC Utrecht, and the Department of Stem Cell Transplantation, Princess Máxima Center for Pediatric Oncology (E.G.M.R., M.B., C.A.L.), Utrecht, and the Department of Pediatrics, Gelre Hospital, Apeldoorn (D.J.P.) - all in the Netherlands.; Revenich EGM

Subjects: Dietary Fats*/Dietary Fats*/Dietary Fats*/adverse effects ; Enzyme Replacement Therapy*/Enzyme Replacement Therapy*/Enzyme Replacement Therapy*/methods ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods

  • Source: The New England journal of medicine [N Engl J Med] 2024 Feb 15; Vol. 390 (7), pp. 623-629.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. Reply.

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/blood ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2024 May 02; Vol. 390 (17), pp. 1634-1635.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.

  • Authors : Wang WD; Sun Yet-sen University Cancer Center, Guangzhou, China.; Gale RP

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/blood ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2024 May 02; Vol. 390 (17), pp. 1633-1634.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Time-Limited Initial Therapy for Young, Fit Patients with CLL.

  • Authors : Woyach JA; From Ohio State University, Columbus (J.A.W.), and the University of Cincinnati, Cincinnati (J.C.B.).; Byrd JC

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy; Humans ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/administration & dosage

  • Source: The New England journal of medicine [N Engl J Med] 2023 May 11; Vol. 388 (19), pp. 1812-1813.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Bridged Bicyclo Compounds, Heterocyclic*/Bridged Bicyclo Compounds, Heterocyclic*/Bridged Bicyclo Compounds, Heterocyclic*/administration & dosage

  • Source: The New England journal of medicine [N Engl J Med] 2023 May 11; Vol. 388 (19), pp. 1739-1754.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.

Subjects: Mycophenolic Acid/Mycophenolic Acid/Mycophenolic Acid/*therapeutic use ; Pemphigus/Pemphigus/Pemphigus/*drug therapy ; Rituximab/Rituximab/Rituximab/*therapeutic use

  • Source: The New England journal of medicine [N Engl J Med] 2021 Jun 17; Vol. 384 (24), pp. 2295-2305. Date of Electronic Publication: 2021 May 19.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.

  • Authors : Tiacci E; From the Institute of Hematology, Ospedale S. Maria della Misericordia, and the Department of Medicine, University of Perugia, Perugia (E.T., L.D.C., E.S., M.C., S.A., V.M.P., B.F.), the Department of Medicine, Section of Hematology, University of Verona, Verona (A. Ambrosetti), the Hematology Unit, Ospedale di Cosenza, Cosenza (E.L.), the Hematology Unit, Department of Transfusional Medicine-SIMMT, Maria Paternò-Arezzo Hospital, Ragusa (A. Antolino), the Hematology Unit, Department of Translational and Precision Medicine, Sapienza University of Rome (A.P., R.F.), and the Hematology and Stem Cell Transplant Unit, A.O. San Camillo Forlanini (L.R.), Rome, the Department of Hematology, Spedali Civili di Brescia, Brescia (S.F.), IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli' and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna (P.L.Z.), the Department of Translational Medicine, Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara (G.G.), the Hematology Unit, Ospedale di Carrara, Carrara (R.D.S.), the Hematology Unit, Ospedale di Frosinone, Frosinone (N.F.), the Hematology Unit, Ospedale di Ronciglione, Viterbo (P.F.), the Hematology Unit, Ospedale di Pesaro, Pesaro (G.V.), and the Hematology Unit, Azienda Sanitaria Universitaria Integrata-Ospedale Maggiore, Trieste (F.Z.) - all in Italy.; De Carolis L

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Leukemia, Hairy Cell/Leukemia, Hairy Cell/Leukemia, Hairy Cell/*drug therapy ; Rituximab/Rituximab/Rituximab/*administration & dosage

  • Source: The New England journal of medicine [N Engl J Med] 2021 May 13; Vol. 384 (19), pp. 1810-1823.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.

Subjects: Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, B-Cell/Lymphoma, B-Cell/Lymphoma, B-Cell/*drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2020 Jun 04; Vol. 382 (23), pp. 2207-2219.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.

  • Authors : Shanafelt TD; From Stanford University, Stanford (T.D.S., S.E.C.), the University of California, Irvine, Medical Center, Orange (S.O.), and Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP)-Permanente Medical Group, Oakland (C.C.Z.) - all in California; Dana-Farber Cancer Institute, Boston (X.V.W., R.M.S.)

Subjects: Immunotherapy*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2019 Aug 01; Vol. 381 (5), pp. 432-443.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*therapeutic use ; Glomerulonephritis, Membranous/Glomerulonephritis, Membranous/Glomerulonephritis, Membranous/*drug therapy ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use

  • Source: The New England journal of medicine [N Engl J Med] 2019 Jul 04; Vol. 381 (1), pp. 36-46.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  324 results for ""RITUXIMAB""